Literature DB >> 17203651

Tetracycline-controlled genetic switches.

R Sprengel1, M T Hasan.   

Abstract

Unlike recombinase-mediated gene manipulations, tetracycline (Tet)-controlled genetic switches permit reversible control of gene expression in the mouse. Trancriptional activation can be induced by activators termed tTA (Tet-Off) or rtTA (Tet-On) in the absence and presence of Tet, respectively. The Tet-Off and Tet-On systems are complementary, and the decision to choose one over the other depends on the particular experimental strategy. Both systems were optimized over the years and can now be used to develop mouse models.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17203651     DOI: 10.1007/978-3-540-35109-2_3

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  30 in total

1.  New methods for tightly regulated gene expression and highly efficient chromosomal integration of cloned genes for Methanosarcina species.

Authors:  Adam M Guss; Michael Rother; Jun Kai Zhang; Gargi Kulkarni; William W Metcalf
Journal:  Archaea       Date:  2008-12       Impact factor: 3.273

2.  Upgrading fungal gene expression on demand: improved systems for doxycycline-dependent silencing in Aspergillus fumigatus.

Authors:  Christoph Helmschrott; Anna Sasse; Sweta Samantaray; Sven Krappmann; Johannes Wagener
Journal:  Appl Environ Microbiol       Date:  2012-12-28       Impact factor: 4.792

3.  Metabolic syndrome in mice induced by expressing a transcriptional activator in adipose tissue.

Authors:  Liwen Zhang; Yuchen Zhou; Amber Ying Zhu; Xiang-qing Li; Steven S Mundt; Ling Gao; JeanMarie Lisnock; Melba Hernandez; Magdalena Alonso-Galicia; Martin S Springer; Edward A O'Neill; Bruce L Daugherty; Oscar Puig
Journal:  Transgenic Res       Date:  2011-10-26       Impact factor: 2.788

Review 4.  Synthetic circuits, devices and modules.

Authors:  Hong Zhang; Taijiao Jiang
Journal:  Protein Cell       Date:  2010-12-10       Impact factor: 14.870

5.  Strategy escalation: an emerging paradigm for safe clinical development of T cell gene therapies.

Authors:  Richard Paul Junghans
Journal:  J Transl Med       Date:  2010-06-10       Impact factor: 5.531

6.  Development of a chromosomally integrated metabolite-inducible Leu3p-alpha-IPM "off-on" gene switch.

Authors:  Maria Poulou; Donald Bell; Kostas Bozonelos; Maria Alexiou; Anthony Gavalas; Robin Lovell-Badge; Eumorphia Remboutsika
Journal:  PLoS One       Date:  2010-08-31       Impact factor: 3.240

7.  Tetracycline-controlled transgene activation using the ROSA26-iM2-GFP knock-in mouse strain permits GFP monitoring of DOX-regulated transgene-expression.

Authors:  Simone Wörtge; Leonid Eshkind; Nina Cabezas-Wallscheid; Bernard Lakaye; Jinhyun Kim; Rosario Heck; Yasmin Abassi; Mustafa Diken; Rolf Sprengel; Ernesto Bockamp
Journal:  BMC Dev Biol       Date:  2010-09-03       Impact factor: 1.978

Review 8.  Animal models of Parkinson's disease: vertebrate genetics.

Authors:  Yunjong Lee; Valina L Dawson; Ted M Dawson
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

9.  Construction and characterization of a doxycycline-inducible transgenic system in Msx2 expressing cells.

Authors:  Congxing Lin; Yan Yin; Hong Chen; Alexander V Fisher; Feng Chen; Michael Rauchman; Liang Ma
Journal:  Genesis       Date:  2009-05       Impact factor: 2.487

Review 10.  Cell-intrinsic signals that regulate adult neurogenesis in vivo: insights from inducible approaches.

Authors:  Madeleine A Johnson; Jessica L Ables; Amelia J Eisch
Journal:  BMB Rep       Date:  2009-05-31       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.